Drugs Similar to L-DOPA 1514

L DOPA

Related medications based on brand, generic name, substance, active ingredients.

By Generic Name

Drugs with the same generic name (different brands)

L-Dopa L DOPA
(L DOPA)
DESERET BIOLOGICALS, INC. FDA OTC

USES: • For the temporary relief of symptoms including: • stiff muscles • tremor • weakness • fatigue These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

L-Dopa L DOPA
(L DOPA)
BIOACTIVE NUTRITIONAL, INC. FDA OTC

USES: For temporary relief of anxiety, chest congestion with constriction, disorientation, shakiness, hay fever, and hives. **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

L DOPA 4X L DOPA
(L DOPA)
BIOACTIVE NUTRITIONAL, INC. FDA OTC

INDICATIONS: For temporary relief of anxiety, chest congestion with constriction, disorientation, shakiness, hay fever, and hives

L-Dopa Phenolic L DOPA
(L DOPA) 49.95 %
ENERGIQUE, INC. FDA OTC

INDICATIONS: May temporarily relieve symptoms associated with reactions to L-Dopa.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

By Substance

Drugs sharing the same substance name

Bio Thalamus Phase ADENOSINUM CYCLOPHOSPHORICUM PETROSELINUM SATIVUM MELATONIN PINEAL GLAND SUIS THALAMUS OPTICUS SUIS L DOPA VISCUM ALBUM APIOLUM
(ADENOSINUM CYCL...)
DESERET BIOLOGICALS, INC. FDA OTC

USES: • For the temporary relief of symptoms including: • neurological support • pain • joint pain • swelling These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
25 mg
MYLAN PHARMACEUTICALS INC. FDA Rx Only

Carbidopa and levodopa extended-release tablets, USP are an extended-release combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.25. It is designated chemically as (-)-L-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.23. Levodopa, USP, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-3-(3,4-Dihydroxyphenyl)-L-alanine. Its molecular formula is C 9 H 11 NO 4 and its structural formula is: Each extended-release tablet, for oral administration, contains either 25 mg of carbidopa and 100 mg of levodopa or 50 mg of carbidopa and 200 mg of levodopa. In addition, each tablet contains the following inactive ingredients: FD&C Blue No. 2 Aluminum Lake, FD&C Red No. 40 Aluminum Lake, hydroxypropyl cellulose, hypromellose, and magnesium stearate. The 25 mg/100 mg tablets are purple, oval, unscored tablets debossed with MYLAN on one side of the tablet and 88 on the other side of the tablet. The 50 mg/200 mg tablets are purple, oval, scored tablets debossed with MYLAN on one side of the tablet and 9 to the left of the score and 4 to the right of the score on the other side of the tablet. Carbidopa and levodopa extended-release tablets are designed in a drug delivery system that controls the release of carbidopa and levodopa as the tablets slowly erode. The 25 mg/100 mg carbidopa and levodopa extended-release tablet is available to facilitate titration and as an alternative to the half-tablet of 50 mg/200 mg carbidopa and levodopa extended-release. FDA approved dissolution test specifications differ from USP. Carbidopa Structural Formula Levodopa Structural Formula

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
10 mg/100 mg
SCIEGEN PHARMACEUTICALS INC FDA Rx Only

Carbidopa and Levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4- dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa is supplied as tablets in three strengths: Carbidopa and Levodopa tablets, USP 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, pregelatinized starch, crospovidone, microcrystalline cellulose, and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue #2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow #10. Carbidopa Chemical Structure Levodopa Chemical Structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
10 mg
RISING PHARMA HOLDINGS, INC. FDA Rx Only

Carbidopa and levodopa orally disintegrating tablets, USP are a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa and levodopa orally disintegrating tablets are an orally administered formulation of carbidopa and levodopa which rapidly disintegrates on the tongue and does not require water to aid dissolution or swallowing. Carbidopa, USP, an inhibitor of aromatic amino acid decarboxylation, is a white to creamy white powder, slightly soluble in water, with a molecular weight of 244.2. It is designated chemically as (-)-L-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.2. Levodopa, USP, an aromatic amino acid, is a white to off-white, odorless crystalline powder, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (-)-3-(3,4-Dihydroxyphenyl)-L-alanine. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa orally disintegrating tablets, USP are supplied as tablets in three strengths: Carbidopa and Levodopa Orally Disintegrating Tablets 10 mg /100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa Orally Disintegrating Tablets 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa Orally Disintegrating Tablets 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are aspartame, crospovidone, mannitol, microcrystalline cellulose, peppermint flavor, silica, sodium stearyl fumarate and sorbitol. In addition, the 25 mg/100 mg tablets contain FD&C Blue No. 1 Aluminum Lake and the 10 mg/100 mg and 25 mg/250 mg tablets contain D&C Yellow No. 10 Aluminum Lake and FD&C Blue No. 1 Aluminum Lake. carbidopa-structural-formula.jpg levodopa-structural-formula.jpg

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
A-S MEDICATION SOLUTIONS FDA Rx Only

Carbidopa and Levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4- dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa is supplied as tablets in three strengths: Carbidopa and Levodopa tablets, USP 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, pregelatinized starch, crospovidone, microcrystalline cellulose, and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue #2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow #10. Carbidopa Chemical Structure Levodopa Chemical Structure

CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA
50 mg/200 mg
SUN PHARMACEUTICAL INDUSTRIES, INC. FDA Rx Only

Carbidopa and levodopa extended-release tablets, USP are extended-release combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.3. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 ·H 2 O and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.3. Levodopa, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 and its structural formula is: Carbidopa and levodopa extended-release tablets, USP are supplied as extended-release tablets containing either 50 mg of carbidopa USP and 200 mg of levodopa USP, or 25 mg of carbidopa USP and 100 mg of levodopa USP. Inactive ingredients: microcrystalline cellulose, colloidal silicon dioxide, hypromellose, hydroxypropyl cellulose, magnesium stearate, red ferric oxide and D&C Yellow 10 Aluminum lake. The 50 mg/200 mg tablet is supplied as an oval, scored, biconvex, compressed tablet debossed “457” on one side and scored on other side that is buff colored with mottled appearance. The 25 mg/100 mg tablet is supplied as an oval, biconvex, compressed tablet debossed “461” on one side and plain on other side that is buff colored with mottled appearance. Carbidopa and levodopa extended-release tablet is a polymeric-based drug delivery system that controls the release of carbidopa and levodopa as it slowly erodes. Carbidopa and levodopa extended-release tablet 25 mg/100 mg is available to facilitate titration when 100 mg steps are required. Meets USP dissolution test 6. carbidopa-structure levodopa-structure

CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA
10 mg/100 mg
XLCARE PHARMACEUTICALS, INC. FDA Rx Only

Carbidopa and levodopa tablets, USP are a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white to creamy-white powder, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-3, 4-dihydroxy-α-methylhydrocinnamic acid monohydrate. Its empirical formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.24. Levodopa, USP an aromatic amino acid, is a white to off-white, crystalline powder, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (2S)-2-Amino-3-(3,4-dihydroxyphenyl) propanoic acid. Its empirical formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa is supplied as tablets in three strengths: Carbidopa and levodopa tablets, USP 10 mg/100 mg containing 10 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets, USP 25 mg/100 mg containing 25 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets, USP 25 mg/250 mg containing 25 mg of carbidopa USP and 250 mg of levodopa USP. Inactive ingredients are microcrystalline cellulose, pregelatinized starch (maize), crospovidone, hydroxypropyl cellulose and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue No.2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow No.10. FDA approved dissolution test specifications differ from USP. Carbidopa Structure Levodopa Structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
A-S MEDICATION SOLUTIONS FDA Rx Only

Carbidopa and Levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4- dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa is supplied as tablets in three strengths: Carbidopa and Levodopa tablets, USP 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, pregelatinized starch, crospovidone, microcrystalline cellulose, and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue #2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow #10. Carbidopa Chemical Structure Levodopa Chemical Structure

Carbidopa and levodopa CARBIDOPA AND LEVODOPA
10 mg/100 mg
AVKARE FDA Rx Only

Carbidopa and levodopa tablets, USP are a combination product for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa Tablets, USP for oral administration, are supplied in three strengths: 10 mg/100 mg, containing 10 mg of carbidopa, USP and 100 mg of levodopa, USP. 25 mg/100 mg, containing 25 mg of carbidopa, USP and 100 mg of levodopa, USP. 25 mg/250 mg, containing 25 mg of carbidopa, USP and 250 mg of levodopa, USP. In addition, each tablet contains the following inactive ingredients: corn starch, magnesium stearate, microcrystalline cellulose, pregelatinized starch (maize). In addition, the 25 mg/100 mg strength contain D&C yellow #10 aluminum lake and FD&C yellow #6 aluminum lake (sunset yellow lake). The 10 mg/100 mg and 25 mg/250 mg strengths contain FD&C blue #2 aluminum lake. 67944b5f-figure-01 67944b5f-figure-02

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
25 mg/100 mg
ALEMBIC PHARMACEUTICALS LIMITED FDA Rx Only

Carbidopa and levodopa extended-release tablets, USP are an extended-release combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP , an inhibitor of aromatic amino acid decarboxylation, is a white to creamy white, odorless or practically odorless powder, freely soluble in 3N hydrochloric acid, slightly soluble in water and in methanol, practically insoluble in alcohol, in acetone, in chloroform and in ether, with a molecular weight of 244.24. It is designated chemically as (-)-L-α­hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.24. Levodopa, USP, an aromatic amino acid, is a white to off-white, odorless , crystalline powder, slightly soluble in water, freely soluble in 3N hydrochloric acid and insoluble in alcohol with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its empirical formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa extended-release tablets, USP are supplied as extended-release tablets containing either 25 mg of carbidopa and 100 mg of levodopa, or 50 mg of carbidopa and 200 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, magnesium stearate, and hypromellose. Carbidopa and levodopa extended-release tablets USP, 25 mg/100 mg and carbidopa and levodopa extended-release tablets USP, 50 mg/200 mg also contain FD&C Blue #2 Aluminium Lake and FD&C Red #40 Aluminium Lake. The 25 mg/100 mg tablet is supplied as an oval shaped mottled tablet that is dappled-purple in color and is debossed with “L519” on one side and plain on the other. The 50 mg/200 mg tablet is supplied as an oval shaped mottled tablet that is dappled-purple in color and is debossed with “L520” on one side and plain on the other. Carbidopa and levodopa extended-release tablets, USP are polymeric-based drug delivery system that controls the release of carbidopa and levodopa as it slowly erodes. Carbidopa and levodopa extended-release tablet 25 mg/100 mg is available to facilitate titration when 100 mg steps are required. FDA approved dissolution specifications differs from the USP dissolution specifications. Structure-Carbidopa Structure-Levodopa

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
25 mg
RADHA PHARMACEUTICALS INC FDA Rx Only

Carbidopa and levodopa extended-release tablets, USP are an extended-release combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa extended-release tablets, USP are supplied as extended-release tablets containing either 25 mg of carbidopa and 100 mg of levodopa, or 50 mg of carbidopa and 200 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, magnesium stearate, hypromellose and also contain FD&C Blue #2. The 25 mg/100 mg tablet is supplied as a light blue, mottled, oval, uncoated tablets debossed with 'SG' on one side and '460' on the other side. The 50 mg/200 mg tablet is supplied as a light blue, mottled, oval, uncoated tablets debossed with 'SG' on one side and '461' on the other side. Carbidopa and levodopa extended-release tablets, USP are polymeric-based drug delivery system that controls the release of carbidopa and levodopa as it slowly erodes. Carbidopa and levodopa extended-release tablet 25 mg/100 mg is available to facilitate titration when 100 mg steps are required. FDA approved dissolution test specifications differ from USP. Carbidopa Chemical Structure Levodopa Chemical Structure

CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA
25 mg/100 mg
NUCARE PHARMACEUTICALS,INC. FDA Rx Only

Carbidopa and levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa USP, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa USP, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 and its structural formula is: Carbidopa and levodopa is supplied as tablets in three strengths: Carbidopa and levodopa tablets, USP, 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and levodopa tablets, USP, 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and levodopa tablets, USP, 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are microcrystalline cellulose, corn starch, pregelatinized maize starch, sodium starch glycolate, magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue 2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow 10 and FD&C Yellow 6. FDA approved dissolution method differs from that of the USP. cdld-structure-carbidopa cdld-structure-levodopa

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
10 mg/100 mg
APHENA PHARMA SOLUTIONS - TENNESSEE, LLC FDA Rx Only

Carbidopa and Levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4- dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa is supplied as tablets in three strengths: Carbidopa and Levodopa tablets, USP 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, pregelatinized starch, crospovidone, microcrystalline cellulose, and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue #2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow #10. Carbidopa Chemical Structure Levodopa Chemical Structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
25 mg
SCIEGEN PHARMACEUTICALS INC FDA Rx Only

Carbidopa and levodopa extended-release tablets, USP are an extended-release combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa extended-release tablets, USP are supplied as extended-release tablets containing either 25 mg of carbidopa and 100 mg of levodopa, or 50 mg of carbidopa and 200 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, magnesium stearate, hypromellose and also contain FD&C Blue #2. The 25 mg/100 mg tablet is supplied as a light blue, mottled, oval, uncoated tablets debossed with 'SG' on one side and '460' on the other side. The 50 mg/200 mg tablet is supplied as a light blue, mottled, oval, uncoated tablets debossed with 'SG' on one side and '461' on the other side. Carbidopa and levodopa extended-release tablets, USP are polymeric-based drug delivery system that controls the release of carbidopa and levodopa as it slowly erodes. Carbidopa and levodopa extended-release tablet 25 mg/100 mg is available to facilitate titration when 100 mg steps are required. FDA approved dissolution test specifications differ from USP. Carbidopa Chemical Structure Levodopa Chemical Structure

CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA
25 mg/100 mg
BRYANT RANCH PREPACK FDA Rx Only

Carbidopa and levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa USP, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa USP, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 and its structural formula is: Carbidopa and levodopa is supplied as tablets in three strengths: Carbidopa and levodopa tablets, USP, 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and levodopa tablets, USP, 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and levodopa tablets, USP, 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are microcrystalline cellulose, corn starch, pregelatinized maize starch, sodium starch glycolate, magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue 2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow 10 and FD&C Yellow 6. FDA approved dissolution method differs from that of the USP.

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
A-S MEDICATION SOLUTIONS FDA Rx Only

Carbidopa and levodopa tablets, USP are a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa USP, an inhibitor of aromatic amino acid decarboxylation, is a white to creamy white powder, freely soluble in 3N hydrochloric acid, slightly soluble in water and methanol, practically insoluble in alcohol, acetone, ether and chloroform, with a molecular weight of 244.3. It is designated chemically as (—)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.3. Levodopa USP, an aromatic amino acid, is a white to off-white, crystalline powder, slightly soluble in water, freely soluble in 3N hydrochloric acid, insoluble in alcohol, with a molecular weight of 197.2. It is designated chemically as (—)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa is supplied as tablets for oral administration in three strengths: Carbidopa and levodopa tablets USP, 25 mg/100 mg containing 25 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets USP, 10 mg/100 mg containing 10 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets USP, 25 mg/250 mg containing 25 mg of carbidopa USP and 250 mg of levodopa USP. Inactive ingredients are crospovidone, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, and pregelatinized starch (maize). Carbidopa and levodopa tablets USP, 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue No.2 Aluminum Lake. Carbidopa and levodopa tablets USP, 25 mg/100 mg also contain D&C Yellow No.10. FDA approved dissolution test specifications differ from USP. chemical structure 1 chemical structure 2

CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA
50 mg/200 mg
BLUEPOINT LABORATORIES FDA Rx Only

Carbidopa and levodopa extended-release tablets USP are for the treatment of Parkinson's disease and syndrome. Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.3. It is designated chemically as (—)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C 10 H 14 N 2 O 4 •H 2 O and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa, which has a molecular weight of 226.3. Levodopa, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (—)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its empirical formula is C 9 H 11 NO 4 and its structural formula is: Each extended-release tablet, for oral administration, contains either 50 mg of carbidopa USP and 200 mg of levodopa USP, or 25 mg of carbidopa USP and 100 mg of levodopa USP. Inactive ingredients: microcrystalline cellulose, lactose monohydrate, hydroxypropyl methyl cellulose, hypromellose, colloidal anhydrous silica, magnesium stearate, ferric oxide red and ferric oxide yellow. The 50 mg/200 mg tablet is supplied as an oval, scored, biconvex, compressed tablet that is peach to light peach colored. The 25 mg/100 mg tablet is supplied as an oval, biconvex, compressed tablet that is peach to light peach colored. Carbidopa and levodopa extended-release tablets USP are designed in a drug delivery system that controls the release of carbidopa and levodopa as it slowly erodes. The 25 mg/100 mg carbidopa and levodopa extended-release tablets USP is available to facilitate titration and as an alternative to the half-tablet of 50 mg/200 mg carbidopa and levodopa extended-release tablets USP. Carbidopa and levodopa extended-release tablets USP meet USP Dissolution Test 5. Carbidopa Chemical Structure Levodopa Chemical Structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
10 mg/100 mg
PROFICIENT RX LP FDA Rx Only

Carbidopa and Levodopa tablet, USP is a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 ∙H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and Levodopa is supplied as tablets in three strengths: Carbidopa and Levodopa tablets, USP 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. Carbidopa and Levodopa tablets, USP 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. Inactive ingredients are hydroxypropyl cellulose, pregelatinized starch, crospovidone, microcrystalline cellulose, and magnesium stearate. Carbidopa and levodopa tablets, USP 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue #2. Carbidopa and levodopa tablets, USP 25 mg/100 mg also contain D&C Yellow #10. Chemical Structure Chemical Structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
10 mg/100 mg
NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS FDA Rx Only

Carbidopa and levodopa tablets are a combination product for the treatment of Parkinson's disease and syndrome. Carbidopa, USP an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.3.. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C 10 H 14 N 2 O 4 .H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23. Levodopa, USP an aromatic amino acid, is a white, crystalline compound, slightly soluble in water with a molecular weight of 197.19. It is designated chemically as (-)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its empirical formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa tablets, USP for oral administration, are supplied in three strengths: 10 mg/100 mg, containing 10 mg of carbidopa and 100 mg of levodopa. 25 mg/100 mg, containing 25 mg of carbidopa and 100 mg of levodopa. 25 mg/250 mg, containing 25 mg of carbidopa and 250 mg of levodopa. In addition, each tablet contains the following inactive ingredients: 10 mg/100 mg — Corn starch, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, and pregelatinized starch (maize). 25 mg/100 mg — Corn starch, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake (sunset yellow lake), magnesium stearate, microcrystalline cellulose, and pregelatinized starch (maize). 25 mg/250 mg — Corn starch, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, and pregelatinized starch (maize). chemical-structure chemical-structure

Carbidopa and Levodopa CARBIDOPA AND LEVODOPA
25 mg/250 mg
BRYANT RANCH PREPACK FDA Rx Only

Carbidopa and levodopa tablets, USP are a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. Carbidopa USP, an inhibitor of aromatic amino acid decarboxylation, is a white to creamy white powder, freely soluble in 3N hydrochloric acid, slightly soluble in water and methanol, practically insoluble in alcohol, acetone, ether and chloroform, with a molecular weight of 244.3. It is designated chemically as (—)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its molecular formula is C 10 H 14 N 2 O 4 •H 2 O, and its structural formula is: Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.3. Levodopa USP, an aromatic amino acid, is a white to off-white, crystalline powder, slightly soluble in water, freely soluble in 3N hydrochloric acid, insoluble in alcohol, with a molecular weight of 197.2. It is designated chemically as (—)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its molecular formula is C 9 H 11 NO 4 , and its structural formula is: Carbidopa and levodopa is supplied as tablets for oral administration in three strengths: Carbidopa and levodopa tablets USP, 25 mg/100 mg containing 25 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets USP, 10 mg/100 mg containing 10 mg of carbidopa USP and 100 mg of levodopa USP. Carbidopa and levodopa tablets USP, 25 mg/250 mg containing 25 mg of carbidopa USP and 250 mg of levodopa USP. Inactive ingredients are crospovidone, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, and pregelatinized starch (maize). Carbidopa and levodopa tablets USP, 10 mg/100 mg and 25 mg/250 mg also contain FD&C Blue No.2 Aluminum Lake. Carbidopa and levodopa tablets USP, 25 mg/100 mg also contain D&C Yellow No.10. FDA approved dissolution test specifications differ from USP.

By Active Ingredients

Drugs sharing any active ingredients

Sambucol Cold and Flu Night Time Syrup Byronia, Chamomilla, Gelsemium Sempervirens, Passiflora Incarnata, Sambucus Nigra, Silicea, Sulphur, Zincum Gluconicum, Water BRYONIA ALBA ROOT BRYONIA ALBA ROOT MATRICARIA RECUTITA MATRICARIA RECUTITA GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT PASSIFLORA INCARNATA FLOWERING TOP PASSIFLORA INCARNATA FLOWERING TOP SAMBUCUS NIGRA FLOWERING TOP SAMBUCUS NIGRA FLOWERING TOP SILICON DIOXIDE SILICON DIOXIDE SULFUR SULFUR ZINC GLUCONATE ZINC CATION ANHYDROUS CITRIC ACID EUROPEAN ELDERBERRY JUICE FRUCTOSE GLYCERIN SODIUM BENZOATE SORBITOL WATER XANTHAN GUM
OTC Limited

INDICATIONS: ​Samucol Cold & Flu Night-Time Relief: ​ - Safe for the whole family* - No known drug interactions - No known side effects - Pleasant berry taste - Fast temporary relief from cold & flu symptoms - Provides a restful night's sleep - With natural elderberry & zinc - Unique homeopathic formulation - Great tasting syrup - Soothing to the throat - Non-habit forming *Children under 4: Consult a doctor before use.

Strength F a-Ketoglutaricum acidum, Isoleucine, L-Arginine, L-Carnitine, Leucine, L-Ornithine, Valine, Estradiol, Folliculinum, Progesterone, Testosterone, Estriol, ISOLEUCINE ISOLEUCINE ARGININE ARGININE CARNITINE CARNITINE .ALPHA.-KETOGLUTARIC ACID .ALPHA.-KETOGLUTARIC ACID LEUCINE LEUCINE ORNITHINE ORNITHINE VALINE VALINE PROGESTERONE PROGESTERONE TESTOSTERONE TESTOSTERONE WATER ALCOHOL ESTRADIOL ESTRADIOL ESTRONE ESTRONE ESTRIOL ESTRIOL
OTC Limited

INDICATIONS: For temporary relief of muscular exhaustion, debility after exercise and lowered vitality in the female after exercise.

Gum Therapy Calendula Officinalis, Eugenia Caryophyllata, Plantago Major, Phytolacca Decandra, Arnica Montana, Phosphorus, Peptostreptococcus, Carbo Vegetabilis, Hepar Sulphuris Calcareum, Lachesis Mutus, Mercurius Solubilis CALENDULA OFFICINALIS FLOWERING TOP CALENDULA OFFICINALIS FLOWERING TOP CLOVE CLOVE PLANTAGO MAJOR PLANTAGO MAJOR PHYTOLACCA AMERICANA ROOT PHYTOLACCA AMERICANA ROOT ARNICA MONTANA ARNICA MONTANA PHOSPHORUS PHOSPHORUS PEPTOSTREPTOCOCCUS ANAEROBIUS PEPTOSTREPTOCOCCUS ANAEROBIUS ACTIVATED CHARCOAL ACTIVATED CHARCOAL CALCIUM SULFIDE CALCIUM SULFIDE LACHESIS MUTA VENOM LACHESIS MUTA VENOM MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS WATER ALCOHOL
OTC Limited

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to gingivitis, inflamed and bleeding gums, pyorrhea, minor pain and ulcerations.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Water Retention Aceticum acidum, apis mellifica, Apocynum cannabinum, Berberis vulgaris, Cahinca, Digitalis purpurea, Helleborus niger, Hydrocotyle asiatica, Natrum muriaticum, Oxydendrum arboreum, Plumbum metallicum, Sambucus nigra, Solidago virgaurea, Strophanthus hispidus ACETIC ACID ACETIC ACID APIS MELLIFERA APIS MELLIFERA APOCYNUM CANNABINUM ROOT APOCYNUM CANNABINUM ROOT BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK CHIOCOCCA ALBA ROOT CHIOCOCCA ALBA ROOT DIGITALIS DIGITALIS HELLEBORUS NIGER ROOT HELLEBORUS NIGER ROOT CENTELLA ASIATICA CENTELLA ASIATICA SODIUM CHLORIDE CHLORIDE ION OXYDENDRUM ARBOREUM LEAF OXYDENDRUM ARBOREUM LEAF LEAD LEAD SAMBUCUS NIGRA FLOWERING TOP SAMBUCUS NIGRA FLOWERING TOP SOLIDAGO VIRGAUREA FLOWERING TOP SOLIDAGO VIRGAUREA FLOWERING TOP STROPHANTHUS HISPIDUS SEED STROPHANTHUS HISPIDUS SEED ANHYDROUS CITRIC ACID POTASSIUM SORBATE WATER
OTC Limited

Uses for temporary relief of symptoms related to common water retention and edema in the hands, feet, legs, ankles, such as: swelling and puffiness, heat intolerance, abdominal bloating, fatigue, unquenchable thrist, suppressed urination.

Allergy Relief Now Chemical Sensitivity Remedy Chemical Sensitivity Remedy ARSENIC TRIOXIDE ARSENIC CATION (3+) PHENOL PHENOL EUPHORBIA RESINIFERA RESIN EUPHORBIA RESINIFERA RESIN CALCIUM SULFIDE CALCIUM SULFIDE HISTAMINE HISTAMINE GOLDENSEAL GOLDENSEAL STRYCHNOS IGNATII SEED STRYCHNOS IGNATII SEED SODIUM CARBONATE CARBONATE ION NUTMEG NUTMEG STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED SULFURIC ACID SULFURIC ACID WATER ALCOHOL
OTC Limited

For frangrances and common chemicals Homeopathic Spray

Diarrhea Relief Aloe socotrina, Chamomilla, Cinchona officinalis, Colocynthis, Croton tiglium, Cuprum arsenicosum, Gelsemium sempervirens, Ipecacuanha, Nux vomica, Phosphoricum acidum, Podophyllum peltatum, Veratrum album ALOE ALOE MATRICARIA RECUTITA MATRICARIA RECUTITA CINCHONA OFFICINALIS BARK CINCHONA OFFICINALIS BARK CITRULLUS COLOCYNTHIS FRUIT PULP CITRULLUS COLOCYNTHIS FRUIT PULP CROTON TIGLIUM SEED CROTON TIGLIUM SEED CUPRIC ARSENITE CUPRIC CATION GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT IPECAC IPECAC STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED PHOSPHORIC ACID PHOSPHORIC ACID PODOPHYLLUM PODOPHYLLUM VERATRUM ALBUM ROOT VERATRUM ALBUM ROOT WATER ANHYDROUS CITRIC ACID POTASSIUM SORBATE
OTC Limited

Uses for temporary relief of diarrhea symptoms: •bloating •loose and watery stools •stomach cramps •sudden stools •mucousy and jelly-like stools •intestinal rumbling •involuntary stools •diarrhea from emotional excitement

FertiCare Agnus castus, Apis mellifica, Aurum metallicum, Borax, Conium maculatum, Ferrum metallicum, Iodium, Lilium tigrinum, Lycopodium clavatum, Natrum muriatcum, Palladium metallicum, sepia CHASTE TREE CHASTE TREE APIS MELLIFERA APIS MELLIFERA GOLD GOLD SODIUM BORATE BORATE ION CONIUM MACULATUM FLOWERING TOP CONIUM MACULATUM FLOWERING TOP IRON IRON IODINE IODINE LILIUM LANCIFOLIUM WHOLE FLOWERING LILIUM LANCIFOLIUM WHOLE FLOWERING LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE SODIUM CHLORIDE CHLORIDE ION PALLADIUM PALLADIUM SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE WATER CITRIC ACID MONOHYDRATE POTASSIUM SORBATE
OTC Limited

Uses for temporary relief of symptoms: vaginal dryness, vaginal discharge, sensitive vagina, itching of female genitals associated with sexual activities, irregular cycles and discomforts during intercourse.

Belladonna Homaccord ATROPA BELLADONNA and ECHINACEA, UNSPECIFIED ATROPA BELLADONNA ATROPA BELLADONNA SODIUM CHLORIDE ECHINACEA, UNSPECIFIED ECHINACEA, UNSPECIFIED
1.1 ml
OTC Limited

INDICATIONS AND USAGE Indications: For the temporary relief of symptoms of localized inflammation:Swelling and RednessSuppurationPain

Steady Remedy No. 14 Aconitum napellus, Alfalfa, Argentum nitricum, Arsenicum album, Aurum metallicum, Avena sativa, Baryta carbonica, Calcarea phosphorica, Chamomilla, Gelsemium sempervirens, Glonoinum, Humulus lupulus, Ignatia amara, Kali arsenicosum, Kali phosphoricum, Muriaticum acidum, Natrum phosphoricum, Passiflora incarnata, Phosphorus, Staphysagria, Stramonium ACONITUM NAPELLUS ACONITUM NAPELLUS ALFALFA ALFALFA SILVER NITRATE SILVER CATION ARSENIC TRIOXIDE ARSENIC CATION (3+) GOLD GOLD AVENA SATIVA FLOWERING TOP AVENA SATIVA FLOWERING TOP BARIUM CARBONATE BARIUM CATION TRIBASIC CALCIUM PHOSPHATE CALCIUM CATION MATRICARIA RECUTITA MATRICARIA RECUTITA GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT NITROGLYCERIN NITROGLYCERIN HOPS HOPS STRYCHNOS IGNATII SEED STRYCHNOS IGNATII SEED POTASSIUM ARSENITE ANHYDROUS ARSENITE ION POTASSIUM PHOSPHATE, DIBASIC PHOSPHATE ION HYDROCHLORIC ACID HYDROCHLORIC ACID SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE PHOSPHATE ION PASSIFLORA INCARNATA FLOWERING TOP PASSIFLORA INCARNATA FLOWERING TOP PHOSPHORUS PHOSPHORUS DELPHINIUM STAPHISAGRIA SEED DELPHINIUM STAPHISAGRIA SEED DATURA STRAMONIUM DATURA STRAMONIUM CITRIC ACID MONOHYDRATE POTASSIUM SORBATE WATER
OTC Limited

Uses: Temporarily relieves symptoms of: anxiety minor mood swings restlessness nervous stomach nervousness irritability stage fright oversensitivity to various stimuli intended to complement, not replace, standard medical care.

Heart Small Intestine Meridian Formula Adrenlinum, Coumarinum, Tyramine, Arteria Suis, Ascorbic Acid, Cactus Grandiflorus, Coenzyme A, Glonoinum, Heart (Suis), Sarcolacticum Acidum, Ubidecarenonum, Vein (Suis), Adrenocorticotrophin, Arsenicum Album, Aurum Metallicum, Belladonna, Digitalis Purpurea, Kali Carbonicum, Lithium Carbonicum, Lycopodium Clavatum, Mercurius Solubilis, Naja Tripudians, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Spigelia Anthelmia, Dysentery Bacillus, Gaertner Bacillus EPINEPHRINE EPINEPHRINE COUMARIN COUMARIN TYRAMINE TYRAMINE SUS SCROFA ARTERY SUS SCROFA ARTERY ASCORBIC ACID ASCORBIC ACID SELENICEREUS GRANDIFLORUS STEM SELENICEREUS GRANDIFLORUS STEM COENZYME A COENZYME A NITROGLYCERIN NITROGLYCERIN PORK HEART PORK HEART LACTIC ACID, L- LACTIC ACID, L- UBIDECARENONE UBIDECARENONE SUS SCROFA VEIN SUS SCROFA VEIN CORTICOTROPIN CORTICOTROPIN ARSENIC TRIOXIDE ARSENIC CATION (3+) GOLD GOLD ATROPA BELLADONNA ATROPA BELLADONNA DIGITALIS DIGITALIS POTASSIUM CARBONATE CARBONATE ION LITHIUM CARBONATE LITHIUM CATION LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS NAJA NAJA VENOM NAJA NAJA VENOM STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED PHOSPHORUS PHOSPHORUS PULSATILLA VULGARIS ANEMONE PULSATILLA SPIGELIA ANTHELMIA SPIGELIA ANTHELMIA SHIGELLA DYSENTERIAE SHIGELLA DYSENTERIAE SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS WATER ALCOHOL
OTC Limited

HOMEOPATHIC INDICATIONS: Temporary relief of symptoms such as upper abdomen pain, flatulence, exercise induced tenderness.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

FNG Berberis Vulgaris, Cochlearia Armoracia, Echinacea (Angustifolia), Hydrastis Canadensis, Lomatium Dissectum, Myrrha, Tabebuia Impetiginosa, Propolis, Formalinum, Glandula Suprarenalis Suis, Thymus (Suis), Ferrum Metallicum, Iridium Metallicum, Lycopodium Clavatum, Phosphoricum Acidum, Pulsatilla (Vulgaris), Selenium Metallicum, Zincum Metallicum, ATP (Adenosine Triphosphate Disodium), Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Pullularia Pullulans BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK HORSERADISH HORSERADISH ECHINACEA ANGUSTIFOLIA ECHINACEA ANGUSTIFOLIA GOLDENSEAL GOLDENSEAL LOMATIUM DISSECTUM ROOT LOMATIUM DISSECTUM ROOT MYRRH MYRRH TABEBUIA IMPETIGINOSA BARK TABEBUIA IMPETIGINOSA BARK PROPOLIS WAX PROPOLIS WAX FORMALDEHYDE FORMALDEHYDE SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND SUS SCROFA THYMUS SUS SCROFA THYMUS IRON IRON IRIDIUM IRIDIUM LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE PHOSPHORIC ACID PHOSPHORIC ACID ANEMONE PULSATILLA WHOLE ANEMONE PULSATILLA WHOLE SELENIUM SELENIUM ZINC ZINC ADENOSINE TRIPHOSPHATE DISODIUM ADENOSINE TRIPHOSPHATE ALTERNARIA ALTERNATA ALTERNARIA ALTERNATA ASPERGILLUS NIGER VAR. NIGER ASPERGILLUS NIGER VAR. NIGER CANDIDA ALBICANS CANDIDA ALBICANS CANDIDA PARAPSILOSIS CANDIDA PARAPSILOSIS MUCOR RACEMOSUS MUCOR RACEMOSUS AUREOBASIDIUM PULLULANS VAR. PULLUTANS AUREOBASIDIUM PULLULANS VAR. PULLUTANS RHIZOPUS STOLONIFER RHIZOPUS STOLONIFER SACCHAROMYCES CEREVISIAE SACCHAROMYCES CEREVISIAE METHYLCOBALAMIN METHYLCOBALAMIN LACTIC ACID, L- LACTIC ACID, L- STACHYBOTRYS CHARTARUM STACHYBOTRYS CHARTARUM ESCHERICHIA COLI ESCHERICHIA COLI WATER ALCOHOL
OTC Limited

INDICATIONS: For temporary relief of symptoms related to fungal, yeast, candida and mold comtamination including, gastritis, constipation, mucous congestion, abdominal gas, headaches, fatigue, alcohol cravings, anxiety‚ vaginitis, rectal itching, cravings for sweets, foggy brain, hyperactivity, mood swings, diarrhea, depression and dizziness.

WellMind Alertness Focus WellMind STEVIA REBAUDIUNA LEAF LACTOSE MAGNESIUM STEARATE SEMECARPUS ANACARDIUM JUICE SEMECARPUS ANACARDIUM JUICE ANAMIRTA COCCULUS SEED ANAMIRTA COCCULUS SEED CONIUM MACULATUM FLOWERING TOP CONIUM MACULATUM FLOWERING TOP KEROSENE KEROSENE SELENIUM SELENIUM CITRIC ACID ACETATE Lightbulb
OTC Limited

Uses Helps restore Mental Focus and Mental Clarity due to fatigue.

Virus Plus Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) HUMAN ADENOVIRUS E SEROTYPE 4 HUMAN ADENOVIRUS E SEROTYPE 4 HUMAN ADENOVIRUS B SEROTYPE 7 HUMAN ADENOVIRUS B SEROTYPE 7 HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 2 HUMAN HERPESVIRUS 2 HUMAN HERPESVIRUS 5 HUMAN HERPESVIRUS 5 HUMAN HERPESVIRUS 4 HUMAN HERPESVIRUS 4 HEPATITIS B VIRUS HEPATITIS B VIRUS NORWALK VIRUS NORWALK VIRUS WATER ALCOHOL
OTC Limited

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, swollen glands, headache and confusion.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Norepinephrine Norepinephrine NOREPINEPHRINE NOREPINEPHRINE WATER ALCOHOL
OTC Limited

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to Norepinephrine sensitivity including rashes, hives, Premenstrual Syndrome, headache, hot flashes, and blurred vision.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Oratox Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenia Caryophyllata, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum FUCUS VESICULOSUS FUCUS VESICULOSUS SUS SCROFA LYMPH SUS SCROFA LYMPH SUS SCROFA BONE MARROW SUS SCROFA BONE MARROW SUS SCROFA THYMUS SUS SCROFA THYMUS SUS SCROFA THYROID SUS SCROFA THYROID CALCIUM CHLORIDE CALCIUM CATION IODINE IODINE SODIUM FLUORIDE FLUORIDE ION SODIUM CHLORIDE CHLORIDE ION SELENIUM SELENIUM VANADIUM VANADIUM SILVER SILVER GOLD GOLD COPPER COPPER EUGENOL EUGENOL FORMALDEHYDE FORMALDEHYDE LIDOCAINE LIDOCAINE MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS MOLYBDENUM MOLYBDENUM NICKEL NICKEL PALLADIUM PALLADIUM TIN TIN TITANIUM TITANIUM ZINC ZINC WATER ALCOHOL
OTC Limited

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heavy metal toxicity caused by toxic dental materials in the mouth. These include muscle cramps, inflammation, mental confusion and joint pain.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Reflux RxS Acetyl Coenzyme A, ATP, Nadidum, Coumarinum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur COENZYME A COENZYME A ADENOSINE TRIPHOSPHATE ADENOSINE TRIPHOSPHATE NADIDE NADIDE COUMARIN COUMARIN SILVER NITRATE SILVER CATION IPECAC IPECAC ROBINIA PSEUDOACACIA BARK ROBINIA PSEUDOACACIA BARK SULFUR SULFUR STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED OREGANO LEAF OIL OREGANO LEAF OIL SUS SCROFA DUODENUM SUS SCROFA DUODENUM SUS SCROFA ESOPHAGUS SUS SCROFA ESOPHAGUS SUS SCROFA UMBILICAL CORD SUS SCROFA UMBILICAL CORD SUS SCROFA STOMACH SUS SCROFA STOMACH CENTAURIUM ERYTHRAEA CENTAURIUM ERYTHRAEA PEPSIN PEPSIN HYDROCHLORIC ACID HYDROCHLORIC ACID ANHYDROUS CITRIC ACID ANHYDROUS CITRIC ACID FORMIC ACID FORMIC ACID LACTIC ACID, L- LACTIC ACID, L- PROTEUS MORGANII PROTEUS MORGANII WATER ALCOHOL
OTC Limited

INDICATIONS AND USAGE For temporary relief of symptoms related to heartburn and esophageal reflux.

Tryptophan Tryptophan TRYPTOPHAN TRYPTOPHAN ALCOHOL WATER
OTC Limited

INDICATIONS: For temporary relief of symptoms related to tryptophan sensitivity including sleep disorders, bloating, colitis, poor digestion, celiac disease, flatulence, gastritis, constipation, digestive malabsorbtion, food sensitivities and Seasonal Affective Disorder.

Chemtox Berberis vulgaris, Glycyrrhiza glabra, Lappa major, Phytolacca decandra, Stillingia sylvatica, Trifolium pratense, Glandula suprarenalis suis, Hepar suis, Lymph suis, Thyroidinum suis, Belladonna, Iridium metallicum Lycopodium clavatum, BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK GLYCYRRHIZA GLABRA GLYCYRRHIZA GLABRA ARCTIUM LAPPA ROOT ARCTIUM LAPPA ROOT PHYTOLACCA AMERICANA ROOT PHYTOLACCA AMERICANA ROOT STILLINGIA SYLVATICA ROOT STILLINGIA SYLVATICA ROOT TRIFOLIUM PRATENSE FLOWER TRIFOLIUM PRATENSE FLOWER SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND PORK LIVER PORK LIVER SUS SCROFA LYMPH SUS SCROFA LYMPH SUS SCROFA THYROID SUS SCROFA THYROID ATROPA BELLADONNA ATROPA BELLADONNA IRIDIUM IRIDIUM LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE NITRIC ACID NITRIC ACID STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED PHOSPHORIC ACID PHOSPHORIC ACID SELENIUM SELENIUM SALICYLIC ACID SALICYLIC ACID CORTICOTROPIN CORTICOTROPIN CORTISONE ACETATE CORTISONE EUGENOL EUGENOL STEARYL ALCOHOL STEARYL ALCOHOL XYLITOL XYLITOL ESTRONE ESTRONE BENZOIC ACID BENZOIC ACID CHLORINE CHLORINE POTASSIUM SORBATE POTASSIUM CATION SORBITOL SORBITOL RESORCINOL RESORCINOL BENZYL ALCOHOL BENZYL ALCOHOL LACTIC ACID, DL- LACTIC ACID, DL- ISOPROPYL PALMITATE ISOPROPYL PALMITATE BORIC ACID BORIC ACID ACETIC ACID ACETIC ACID PHENYLBUTAZONE PHENYLBUTAZONE PETROLATUM PETROLATUM LEAD LEAD WATER ALCOHOL
OTC Limited

INDICATIONS: For temporary relief of symptoms related to chemical toxicity including fatigue, frequent colds, insomnia, headache, rash, depression, sinusitis, constipation, poor circulation, and memory difficulties.

Alcoholism Aesculus hippocastanum, flos, Agrimonia eupatoria, flos, Apocynum cannabinum, Arsenicum album, Asarum europaeum, Avena sativa, Capsicum annuum, Carboneum sulphuratum, Gelsumium sempervirens, Helianthus annuus, Juglans regia, flos, Lonicera caprifolium, flos, Naja tripudians, Paullinia sorbilis. AESCULUS HIPPOCASTANUM FLOWER AESCULUS HIPPOCASTANUM FLOWER AGRIMONIA EUPATORIA FLOWER AGRIMONIA EUPATORIA FLOWER APOCYNUM CANNABINUM ROOT APOCYNUM CANNABINUM ROOT ARSENIC TRIOXIDE ARSENIC CATION (3+) ASARUM EUROPAEUM ASARUM EUROPAEUM AVENA SATIVA FLOWERING TOP AVENA SATIVA FLOWERING TOP CAPSICUM CAPSICUM CARBON DISULFIDE CARBON DISULFIDE GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT HELIANTHUS ANNUUS FLOWERING TOP HELIANTHUS ANNUUS FLOWERING TOP JUGLANS REGIA FLOWERING TOP JUGLANS REGIA FLOWERING TOP LONICERA CAPRIFOLIUM FLOWERING TOP LONICERA CAPRIFOLIUM FLOWERING TOP NAJA NAJA VENOM NAJA NAJA VENOM PAULLINIA CUPANA SEED PAULLINIA CUPANA SEED WATER CITRIC ACID MONOHYDRATE POTASSIUM SORBATE
OTC Limited

Uses a natural aid for: emotional and physical effects of alcohol, alcoholic tendencies or predisposition, discontent, irritability.

Lyme HP Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode, Arsenicum Album, Bryonia (Alba), Chelidonium Majus, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox BAPTISIA TINCTORIA ROOT BAPTISIA TINCTORIA ROOT ECHINACEA ANGUSTIFOLIA ECHINACEA ANGUSTIFOLIA GOLDENSEAL GOLDENSEAL BORRELIA BURGDORFERI BORRELIA BURGDORFERI BABESIA MICROTI BABESIA MICROTI EHRLICHIA CANIS EHRLICHIA CANIS JAPANESE ENCEPHALITIS VIRUS JAPANESE ENCEPHALITIS VIRUS NEISSERIA MENINGITIDIS NEISSERIA MENINGITIDIS HEPATITIS B VIRUS HEPATITIS B VIRUS ARSENIC TRIOXIDE ARSENIC CATION (3+) BRYONIA ALBA ROOT BRYONIA ALBA ROOT CHELIDONIUM MAJUS CHELIDONIUM MAJUS COLCHICUM AUTUMNALE BULB COLCHICUM AUTUMNALE BULB KALMIA LATIFOLIA LEAF KALMIA LATIFOLIA LEAF LEDUM PALUSTRE TWIG LEDUM PALUSTRE TWIG LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE PHOSPHORUS PHOSPHORUS TOXICODENDRON PUBESCENS LEAF TOXICODENDRON PUBESCENS LEAF WATER ALCOHOL
4.53 %
OTC Limited

INDICATIONS: May temporarily relieve symptoms associated with infections, such as aches and pains of joints and muscles.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

← Back to L-DOPA 1514